Nyxoah SA Logo

Nyxoah SA (5YI)

FSX

Currency in EUR
1.49
+0.07 (+5.07%)

Real-time Data

06:00 AM

Day's Range

1.49
1.60

52 wk Range

1.22
7.65

Overview - 5YI - Nyxoah SA

Key Statistics

Valuation

Enterprise Value

91.49M

P/E (Trailing)

‪-0.53‬

P/E (Forward)

‪-0.88‬

PEG Ratio

‪-0.11‬

Price / Sales (TTM)

‪5.89‬

Price / Book

‪1.53‬

EV / EBITDA

‪-1.10‬

Profitability

Gross Margin

‪59.72%‬

Profit Margin

‪63.13%‬

Operating Margin

‪-268.24%‬

Return on Assets

‪-36.86%‬

Return on Equity

‪-122.68%‬

Ownership

Shares Outstanding

100.07M

Float

50.88M

Held by Insiders

‪33.19%‬

Held by Institutions

‪29.90%‬

Price stats

Beta

‪0.94‬

50-Day Avg

‪1.28‬

200-Day Avg

‪2.74‬

Dividends

Payout Ratio

‪0.00%‬

Peers - 5YI - Nyxoah SA

Peer Comparison

Compared with companies in Medical Instruments & Supplies listed on FSX.

Profile Summary - 5YI - Nyxoah SA

About

Nyxoah SA is a medical technology company specializing in the development and commercialization of innovative solutions for treating obstructive sleep apnea (OSA). Its flagship product, the Genio system, offers a CE-marked, patient-centric, minimally invasive hypoglossal neurostimulation therapy designed for moderate…

SectorHealthcare
IndustryMedical Instruments & Supplies
Employees153
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.